The interaction of nonglycoside cardiotonic agents with other drug preparations
Grinevich, A.I.; Chekman, I.S.; Roshchupkina, E.V.; Angelutsa, P.A.
Kardiologiia 33(6): 56-61
1993
ISSN/ISBN: 0022-9040 PMID: 8377367 Document Number: 417372
Document emailed within 1 workday
Related Documents
Chubarev, V.N. 1990: The incompatibility of antihistamine preparations with other drug agents Meditsinskaia Sestra 49(6): 43-48Jaillon, P. 1983: New cardiotonic agents Presse Medicale 12(33): 2027-2029
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Zisel'man, S.B.; Sivkov, S.I. 1978: Tetrapolar rheography in the study of pharmacodynamics of cardiotonic agents Sovetskaia Meditsina 9: 87-90
Forina, M.; Boggia, R.; Mosti, L.; Fossa, P. 1997: Zupan's descriptors in QSAR applied to the study of a new class of cardiotonic agents Farmaco 52(6-7): 411-419
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Earl, C.Q.; Linden, J.; Weglicki, W.B. 1986: Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone Journal of Cardiovascular Pharmacology 8(4): 864-872
Diederen, W.; Weisenberger, H. 1981: Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug Arzneimittel-Forschung 31(1a): 177-182
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Mel'nik, S.I.; Bakhmedova, A.A.; Iartseva, I.V.; Preobrazhenskaia, M.N.; Zaguliaeva, O.A.; Mamaev, V.P. 1991: Search for antimetabolites among 5-trimethylsilyluracil nucleosides and their nonglycoside analogs Bioorganicheskaia Khimiia 17(11): 1526-1533
Murav'ev, I.V.; Akparov, V.K.; Krasil'nikova, O.A.; Zhankin, A.A.; Sigidin, I.A. 1988: Pharmacokinetics and interaction of antirheumatic preparations Klinicheskaia Meditsina 66(8): 62-65
Senf, H.J.; Wollmann, H. 1975: The use of spectroscopic methods for the detection of drug sorption in polyethylene containers. 15. the problem of synthetic container inserts for liquid drug preparations Die Pharmazie 30(5): 301-303
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Gupta, R.; Wu, J.J.; Levin, E.; Koo, J.Y.M.; Liao, W. 2013: Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient Journal of Drugs in Dermatology: Jdd 12(10): 1089
Hahn, M.; Braus, D.F. 2012: Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention Versicherungsmedizin 64(3): 127-131
Davidson, K.W.; Kahn, A.; Price, R.D. 1987: Reduction of adverse drug reactions by computerized drug interaction screening Journal of Family Practice 25(4): 371-375
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Yasuda, K.; Tsurumi, K.; Fujimura, H. 1986: Study of drug interaction between the new antiallergic drug 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and theophylline Arzneimittel-Forschung 36(11): 1642-1646
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13